Compare · MGRX vs SHC
MGRX vs SHC
Side-by-side comparison of Mangoceuticals Inc. (MGRX) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MGRX and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $4.52B, about 725.8x MGRX ($6.2M).
- Over the past year, MGRX is down 81.5% and SHC is up 28.7% - SHC leads by 110.2 points.
- SHC has been more active in the news (16 items in the past 4 weeks vs 1 for MGRX).
- SHC has more recent analyst coverage (25 ratings vs 0 for MGRX).
- Company
- Mangoceuticals Inc.
- Sotera Health Company
- Price
- $0.37+5.50%
- $15.86+1.44%
- Market cap
- $6.2M
- $4.52B
- 1M return
- +4.28%
- +1.21%
- 1Y return
- -81.47%
- +28.73%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2020
- News (4w)
- 1
- 16
- Recent ratings
- 0
- 25
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest MGRX
- SEC Form 10-Q filed by Mangoceuticals Inc.
- SEC Form NT 10-Q filed by Mangoceuticals Inc.
- SEC Form 10-K filed by Mangoceuticals Inc.
- SEC Form NT 10-K filed by Mangoceuticals Inc.
- SEC Form 4 filed by Cohen Jacob D.
- SEC Form 4 filed by Cohen Jacob D.
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
- Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest SHC
- Goldman initiated coverage on Sotera Health with a new price target
- SEC Form SD filed by Sotera Health Company
- Director Klee Ann R. was granted 14,970 shares, increasing direct ownership by 12% to 140,926 units (SEC Form 4)
- Chief Executive Officer Shader Alton was granted 579,573 shares (SEC Form 4)
- SEC Form 3 filed by new insider Shader Alton
- Director Kyle Richard G was granted 14,970 shares (SEC Form 4)
- Director Krause Kenneth D. was granted 14,970 shares (SEC Form 4)
- Director Cunningham Sean Laurence was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)
- Director Flynn Karen was granted 14,970 shares, increasing direct ownership by 38% to 54,191 units (SEC Form 4)
- Director Neary James was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)